Longevity & Aging · Metabolic & Cardiometabolic
testosterone therapy increases bone mineral density
In plain terms: Does testosterone therapy strengthen bones?
Part of: 💊 Testosterone therapy (TRT)
It increases bone density on scans, most clearly in the spine. But — importantly — no trial has shown it actually reduces broken bones (one 2026 analysis even found more fractures), so denser bone hasn't yet translated into fewer breaks. Oddly, the benefit comes mostly from estrogen your body makes from testosterone, not testosterone itself.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Testosterone therapy **increases bone mineral density**, most clearly in the **spine** (trabecular bone) and less consistently at the hip/femoral neck — the strongest evidence is the Testosterone Trials' Bone Trial. Two important honesty caveats: (1) **no trial has shown TRT reduces actual fractures** (one 2026 meta-analysis even found a higher clinical-fracture rate), so denser bone has not trans
The evidence (14)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Isidori AM et al. 2005 · Clin Endocrinol (Oxf) | meta-analysis | supports | moderate | Meta 29 RCTs: lumbar spine BMD +3.7% vs placebo; no significant femoral-neck effect. |
| de Silva NL et al. 2024 · Lancet Diabetes Endocrinol | mechanism | supports | low | Review (Lancet Diab Endo): TRT improves BMD and insulin sensitivity in functional hypogonadism; insufficient evidence for fracture prevention. |
| Snyder PJ et al. 1999 · J Clin Endocrinol Metab | RCT | mixed | moderate | RCT (>65y): no overall group difference in lumbar BMD, but men with lowest baseline T gained (+5.9% vs +0.9%). |
| Zhang J et al. 2019 · Aging Male | meta-analysis | contradicts | low | Meta 7 RCTs: TRT did NOT significantly reverse BMD decline at spine/femoral neck/whole body (only trochanter/hip). |
| Ng Tang Fui M et al. 2021 · Lancet Diabetes Endocrinol | RCT | supports | high | T4DM substudy: 2-yr TRT increased tibial/radial cortical vBMD (~3%) and lumbar/total-hip aBMD. |
| Guo C et al. 2016 · Andrologia | meta-analysis | tested-null | moderate | Meta 16 RCTs: no significant difference in BMD (MD -0.01, 95% CI -0.03 to 0.02). |
| Anagnostis P et al. 2026 · Endocrine | meta-analysis | mixed | moderate | Fracture meta (2 RCTs, n=2711): higher overall clinical-fracture risk (RR 1.55) but not major osteoporotic fractures (RR 0.62 ns) - BMD gains not translating to fewer fractures. |
| de Silva NL et al. 2025 · Clin Endocrinol (Oxf) | meta-analysis | supports | moderate | SR/meta (hypogonadotropic hypogonadism, n=625): low BMD improves with hormone treatment, often incomplete normalization. |
| Dias JP et al. 2016 · J Clin Endocrinol Metab | RCT | supports | low | RCT (65-82y): TRT improved primary outcome lumbar spine BMD at 12 months. |
| Buratto J et al. 2023 · Arch Endocrinol Metab | meta-analysis | mixed | moderate | Meta 16 RCTs: increased hip BMD at 6 months; effects unclear for lumbar spine and at 12 months. |
| Finkelstein JS et al. 2016 · J Clin Invest | mechanism | supports | moderate | Dose-ranging mechanistic RCT: estrogen (from T aromatization), not testosterone per se, is the primary driver of BMD maintenance. |
| Basurto L et al. 2008 · Aging Male | RCT | supports | low | RCT (elderly): TRT increased lumbar spine BMD significantly; no femoral-neck change. |
| Snyder PJ et al. 2017 · JAMA Intern Med | RCT | supports | high | T-Trials Bone Trial (>=65y): spine trabecular vBMD +6.8% treatment effect and greater estimated bone strength vs placebo. |
| Bouloux PM et al. 2013 · J Clin Endocrinol Metab | RCT | supports | moderate | Dose-ranging RCT (n=322): oral testosterone undecanoate increased spine/hip/trochanter BMD dose-dependently. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.